Ilan Daskal

Track

Insider profile

Currently holds positions in Infineon Technologies Americas Corp, Bio-Rad Laboratories, Inc. and Natus Medical Inc

Performance

Overall performance
1.1
Performance over holding periods
1.1
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Infineon Technologies Americas Corp Oct. 6, 2008 -
Chief Financial Officer, Executive Vice President Bio-Rad Laboratories, Inc. April 6, 2019 -
Independent Director Natus Medical Inc March 19, 2020 -
Independent Director Ixia June 26, 2015 - April 18, 2017
Director TerraForm Global Inc March 30, 2016 - July 24, 2016
Chief Financial Officer - Designee and Executive Vice President Sunedison Inc April 4, 2016 - June 27, 2016
Chief Financial Officer, Executive Vice President Cepheid April 9, 2015 - Aug. 13, 2015
Ilan Daskal's trades of Viavi Solutions Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
350.22
Quantity 34,528
Value US$2,812,790
Transaction date
Sale
Price
34.66
Quantity 2,325 -45.9%
Value US$2,197,520
Transaction date
Sale
Price
367.76
Quantity 88,944 -19.5%
Value US$2,566,002
Transaction date
Sale
Price
17.43
Quantity 105,191 -91.2%
Value US$1,833,479
Transaction date
Sale
Price
17.42
Quantity 39,709 -25.6%
Value US$691,731
Transaction date
Sale
Price
17.84
Quantity 25,100 -13.9%
Value US$447,784
Transaction date
Proposed sale
Price
17.49
Quantity 170,000
Value US$2,973,005
Transaction date
Sale
Price
9.28
Quantity 82,095 -100.0%
Value US$761,842
Transaction date
Proposed sale
Price
9.28
Quantity 82,095
Value US$762,080
Transaction date
Sale
Price
27.46
Quantity 2,500 -22.4%
Value US$68,650
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-31 2026-08-31
PrS Proposed sale
34,528
350.22
US$2,812,790 		34,528 350.22 US$2,812,790
2026-08-31 2026-08-31
S Sale
2,325 -45.9%
34.66
US$2,197,520 		2,325 -45.9% 34.66 US$2,197,520
2026-08-31 2026-08-31
S Sale
88,944 -19.5%
367.76
US$2,566,002 		88,944 -19.5% 367.76 US$2,566,002
2025-12-03 2025-12-02
S Sale
105,191 -91.2%
17.43
US$1,833,479 		105,191 -91.2% 17.43 US$1,833,479
2025-12-03 2025-12-02
S Sale
39,709 -25.6%
17.42
US$691,731 		39,709 -25.6% 17.42 US$691,731
2025-12-03 2025-12-02
S Sale
25,100 -13.9%
17.84
US$447,784 		25,100 -13.9% 17.84 US$447,784
2025-12-02 2025-12-02
PrS Proposed sale
170,000
17.49
US$2,973,005 		170,000 17.49 US$2,973,005
2025-06-06 2025-06-04
S Sale
82,095 -100.0%
9.28
US$761,842 		82,095 -100.0% 9.28 US$761,842
2025-06-04 2025-06-04
PrS Proposed sale
82,095
9.28
US$762,080 		82,095 9.28 US$762,080
2025-05-27 2025-05-23
S Sale
7,716
5.00
₹38,580 		7,716 5.00 ₹38,580
2021-06-15 2021-06-11
S Sale
2,500 -22.4%
27.46
US$68,650 		2,500 -22.4% 27.46 US$68,650